Cancer Research Institute (CRI): Technology Impact Award – LOI

Designed to support early-stage, pre-development concepts — innovations that have not yet been built or tested, but that hold the potential to transform the landscape of cancer immunotherapy.
The most competitive applicants will propose innovations that address areas where technological advancement can have the greatest impact on cancer immunotherapy and patient outcomes. Such technologies may include, but are not limited to:
Computational systems biology approaches, Advanced cancer (or molecular) profiling technologies, Real-time visualization technologies, Complex multicellular culture systems and Novel therapeutic technologies.
Funding: seed funding of up to $600K over 2-4 years (10% overhead in addition to awarded funds)
https://www.cancerresearch.org/technology-impact-award